Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M D, Scholl"'
Autor:
M D Scholl, D C Young, M B Tighe, K S Theil, P S Belt, Belinda R. Avalos, Sam Penza, Edward A. Copelan, Patrick Elder, T P Bechtel, S A Ezzone
Publikováno v:
Bone Marrow Transplantation. 26:1037-1043
Results in 164 patients who underwent allogeneic marrow transplantation following busulfan and cyclophosphamide over a 15 year period were analyzed. Age (median 37, range 14-66 years) did not significantly affect the incidence of graft-versus-host di
Autor:
Belinda R. Avalos, S A Ezzone, G L Risley, T P Bechtel, D D Marshall, L C Lasky, Patrick Elder, Edward A. Copelan, Sarah K. Ceselski, Sam Penza, J. L. Klein, D M Hehmeyer, M D Scholl
Publikováno v:
Journal of Clinical Oncology. 15:759-765
PURPOSE We analyzed the safety and effectiveness of high-dose etoposide (2 g/m2) followed by granulocyte colony-stimulating factor (G-CSF) as a peripheral-blood progenitor cell (PBPC) mobilization regimen and assessed extent of tumor reduction in pat
Autor:
T P Bechtel, Patrick Elder, S Hoshaw-Woodard, Sherif S. Farag, S A Ezzone, Guido Marcucci, Thomas S. Lin, M D Scholl, Stanley Lemeshow, Edward A. Copelan, Sam Penza, Belinda R. Avalos
Publikováno v:
Bone Marrow Transplantation. 34:85-87
The use of VP-16 for stem cell mobilization has been cited as a significant risk factor for the development of therapy-related myelodysplasia/leukemia (tMDS/tAML) following autologous transplantation. The present study analyzed a large cohort of pati
Autor:
M D Scholl, Belinda R. Avalos, Patrick Elder, S A Ezzone, Sam Penza, T P Bechtel, Edward A. Copelan
Publikováno v:
Bone marrow transplantation. 27(11)
Long-term outcome was analyzed in 28 patients transplanted between 1989 and 1992 following busulfan and cyclophosphamide and who had busulfan levels studied. While there was no significant correlation of busulfan levels with diagnosis, patients who h
Autor:
E A, Copelan, S L, Penza, P J, Elder, P S, Belt, M D, Scholl, D M, Hehmeyer, S A, Ezzone, T P, Bechtel, B R, Avalos
Publikováno v:
Bone marrow transplantation. 18(5)
Between March 1984 and March 1995, 76 patients with advanced acute myelogenous, acute lymphoblastic, or chronic myelogenous leukemia underwent allogeneic marrow transplantation from HLA-identical or one-antigen mismatched sibling or unrelated donors.
Autor:
J L, Klein, B R, Avalos, P, Belt, C A, Taylor, S A, Ezzone, M D, Scholl, J, Fisher, D, Young, E A, Copelan
Publikováno v:
Bone marrow transplantation. 17(4)
Two major problems of unrelated donor transplantation have been an increased incidence of GVHD and graft failure. Even with HLA identity by microlymphocytotoxicity assay and non-reactive MLC, URD marrow transplant recipients have a higher incidence o
Autor:
C L Geshekter, M D Scholl
Publikováno v:
Journal of the Royal Society of Medicine. 82:679-680